CONTEXT: The challenge to provide a palliative care service for individuals with advanced neurological conditions is compounded by variability in disease trajectories and symptom profiles. The National End of Life Care Programme (2010) recommended seven 'triggers' for a palliative approach to care for patients with advanced neurological conditions. OBJECTIVES: To establish the frequency of triggers in the palliative phase, and if they could be reduced to fewer components. Management of the terminal phase also was evaluated. METHOD: Retrospective study of 62 consecutive patients under the care of a specialist palliative neurology service, who had died. Principle component analysis (PCA) was performed to establish the interrelationship between triggers. RESULTS: Frequency of triggers increased as each patient approached death. PCA found that four symptom components explained 76.8% of the variance. These represented: rapid physical decline; significant complex symptoms, including pain; infection in combination with cognitive impairment; and risk of aspiration. Median follow-up under the palliative care service was 336 days. In 56.5% of patients, the cause of death was pneumonia. The terminal phase was recognised in 72.6%. The duration of the terminal phase was 8.8 days on average, and the Liverpool Care of the dying Pathway was commenced in 33.9%. All carers were offered bereavement support. CONCLUSIONS: Referral criteria based on the triggers can facilitate appropriate and timely patient access to palliative care. The components deduced through PCA have face validity; however larger studies prospectively validating the triggers are required. Closer scrutiny of the terminal phase is necessary to optimise management.
CONTEXT: The challenge to provide a palliative care service for individuals with advanced neurological conditions is compounded by variability in disease trajectories and symptom profiles. The National End of Life Care Programme (2010) recommended seven 'triggers' for a palliative approach to care for patients with advanced neurological conditions. OBJECTIVES: To establish the frequency of triggers in the palliative phase, and if they could be reduced to fewer components. Management of the terminal phase also was evaluated. METHOD: Retrospective study of 62 consecutive patients under the care of a specialist palliative neurology service, who had died. Principle component analysis (PCA) was performed to establish the interrelationship between triggers. RESULTS: Frequency of triggers increased as each patient approached death. PCA found that four symptom components explained 76.8% of the variance. These represented: rapid physical decline; significant complex symptoms, including pain; infection in combination with cognitive impairment; and risk of aspiration. Median follow-up under the palliative care service was 336 days. In 56.5% of patients, the cause of death was pneumonia. The terminal phase was recognised in 72.6%. The duration of the terminal phase was 8.8 days on average, and the Liverpool Care of the dying Pathway was commenced in 33.9%. All carers were offered bereavement support. CONCLUSIONS: Referral criteria based on the triggers can facilitate appropriate and timely patient access to palliative care. The components deduced through PCA have face validity; however larger studies prospectively validating the triggers are required. Closer scrutiny of the terminal phase is necessary to optimise management.
Entities:
Keywords:
End-of-life; Neurological conditions; Prognosis; Terminal care
Authors: Katherine R Courtright; Corey Chivers; Michael Becker; Susan H Regli; Linnea C Pepper; Michael E Draugelis; Nina R O'Connor Journal: J Gen Intern Med Date: 2019-07-16 Impact factor: 5.128
Authors: Sarah K Andersen; Grace Vincent; Rachel A Butler; Elke H P Brown; Dave Maloney; Sana Khalid; Rae Oanesa; James Yun; Carrie Pidro; Valerie N Davis; Judith Resick; Aaron Richardson; Kimberly Rak; Jackie Barnes; Karl B Bezak; Andrew Thurston; Eva Reitschuler-Cross; Linda A King; Ian Barbash; Ali Al-Khafaji; Emily Brant; Jonathan Bishop; Jennifer McComb; Chung-Chou H Chang; Jennifer Seaman; Jennifer S Temel; Derek C Angus; Robert Arnold; Yael Schenker; Douglas B White Journal: J Pain Symptom Manage Date: 2022-06 Impact factor: 5.576
Authors: April Zehm; Amanda M Hazeltine; Joseph A Greer; Lara Traeger; Margaret Nelson-Lowe; Kate Brizzi; Juliet Jacobsen Journal: Neurol Clin Pract Date: 2020-12
Authors: Roberta I Jordan; Matthew J Allsop; Yousuf ElMokhallalati; Catriona E Jackson; Helen L Edwards; Emma J Chapman; Luc Deliens; Michael I Bennett Journal: BMC Med Date: 2020-11-26 Impact factor: 8.775